Biopharmaceutical Financialization and Public Funding of Medical Countermeasures (MCMs) in Canada During the COVID-19 Pandemic

por Eren Vural, Ipek, Herder, Matthew, Doll, Agnieszka, Graham, Janice E.
Publicado 2023

Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

por Edmonds, Sterling, MacGregor, Andrea, Doll, Agnieszka, Vural, Ipek Eren, Graham, Janice, Fierlbeck, Katherine, Lexchin, Joel, Doshi, Peter, Herder, Matthew
Publicado 2020